The Role of Circulating CD16+CD56+ Natural Killer Cells in the Screening, Diagnosis, and Staging of Colorectal Cancer before Initial Treatment

<div>Receiver Operating Characteristic (ROC) curve of NK cells in the prediction of CRC cases (healthy vs. cases).</div>

Disease Markers

fig1

Figure 1

Figure 1: The Role of Circulating CD16+CD56+ Natural Killer Cells in the Screening, Diagnosis, and Staging of Colorectal Cancer before Initial Treatment 

Figure 1 | The Role of Circulating CD16+CD56+ Natural Killer Cells in the Screening, Diagnosis, and Staging of Colorectal Cancer before Initial Treatment 